Eur Respir J 1997; 10: 2731-2737
Copyright © ERS Journals Ltd 1997
Proteoglycans in granulomatous lung diseases
ES Bensadoun,
AK Burke,
JC Hogg,
and
CR Roberts
In nongranulomatous fibrotic lung conditions, we have recently shown that early collagen synthesis by myofibroblasts occurs in an extracellular matrix rich in the proteoglycan versican. We hypothesized that versican is associated with the process of collagen synthesis resulting from chronic inflammation. In this study, we examined the localization of proteoglycans and collagen in the granulomatous lung conditions, sarcoidosis, extrinsic allergic alveolitis (EAA) and tuberculosis (TB). Tissue from individuals with sarcoidosis (n=6), EAA (n=4) and TB (n=2) was examined for glycosaminoglycans and collagen using histochemistry, and for versican, decorin, biglycan, hyaluronan, type I procollagen and alpha-smooth muscle actin using immunohistochemistry. The results showed that in sarcoidosis, EAA and TB, the rim of connective tissue surrounding granulomas contained glycosaminoglycans and collagen, and that glycosaminoglycan staining corresponded to localization of versican. Versican-rich zones contained myofibroblasts that stained intracellularly for type I procollagen. Hyaluronan was found diffusely throughout the matrix. Decorin was localized intracellularly in the epithelioid cells of granulomas and some myofibroblasts. We conclude that the deposition of versican is specific to the early remodelling process in both granulomatous and nongranulomatous lung diseases. In both forms of lung fibrosis, regardless of the nature of the driving inflammatory process, collagen synthesis takes place in a versican-rich provisional matrix. These results suggest that versican may influence the progression of the repair process following many different types of lung injury.
This article has been cited by other articles:

|
 |

|
 |
 
D. S. Faffe and W. A. Zin
Lung Parenchymal Mechanics in Health and Disease
Physiol Rev,
July 1, 2009;
89(3):
759 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Koninger, N A Giese, M Bartel, F F di Mola, P O Berberat, P di Sebastiano, T Giese, M W Buchler, and H Friess
The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis
J. Clin. Pathol.,
January 1, 2006;
59(1):
21 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Frevert and P. L. Sannes
Matrix proteoglycans as effector molecules for epithelial cell function
Eur. Respir. Rev.,
December 1, 2005;
14(97):
137 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Frevert, M. G. Kinsella, C. Vathanaprida, R. B. Goodman, D. G. Baskin, A. Proudfoot, T. N. C. Wells, T. N. Wight, and T. R. Martin
Binding of Interleukin-8 to Heparan Sulfate and Chondroitin Sulfate in Lung Tissue
Am. J. Respir. Cell Mol. Biol.,
April 1, 2003;
28(4):
464 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Koslowski, U. Pfeil, H. Fehrenbach, M. Kasper, E. Skutelsky, and K-W. Wenzel
Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat
Eur. Respir. J.,
August 1, 2001;
18(2):
347 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. EBIHARA, N. VENKATESAN, R. TANAKA, and M. S. LUDWIG
Changes in Extracellular Matrix and Tissue Viscoelasticity in Bleomycin-induced Lung Fibrosis . Temporal Aspects
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1569 - 1576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Hall, A. A. Hislop, C. M. Pierce, and S. G. Haworth
Prenatal Origins of Human Intrapulmonary Arteries . Formation and Smooth Muscle Maturation
Am. J. Respir. Cell Mol. Biol.,
August 1, 2000;
23(2):
194 - 203.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the European Respiratory Society.
|